Yiyue Zhang

23PUBLICATIONS
81CO-AUTHORS
Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 23, 2026
Co-mutation of asxl1 and IDH2R172K enhances leukemogenesis and correlates with epigenetic activation of MAPK and AP-1.

|Jun 25, 2026
Author Correction: ATF7IP/SETDB1-mediated epigenetic programming regulates thymic homing and T lymphopoiesis of hematopoietic progenitors during embryogenesis.

|Nov 03, 2025
asxl1 C-terminal truncation and SRSF2 mutation drive leukemogenesis via immune reprogramming.

Lingge Tu, Fangfang He, Jun Mun Liew

|Jul 16, 2025
ATF7IP/SETDB1-mediated epigenetic programming regulates thymic homing and T lymphopoiesis of hematopoietic progenitors during embryogenesis.

Wenqi Chen, Jiaxin Wu, Peilu She

|Feb 28, 2025
The synergistic effect of c-Myb hyperactivation and Pu.1 deficiency induces Pelger-Huët anomaly and promotes sAML.

Song'en Xu, Jiaxin Hong, Meimei Dongye

|Dec 17, 2024
Identification of novel germline mutations in FUT7 and EXT1 linked with hereditary multiple exostoses.

Wan Peng, Gao-Fei Li, Guo-Wang Lin

Pageof 4

Frequent Collaborators

7 joint publications

Wenqing Zhang

5 joint publications

Jin Xu

5 joint publications

Zhibin Huang

4 joint publications

Mei Wu